Get the Stockscreener App
16.88
2.37%
-0.425
After Hours:
16.88
Pulse Biosciences Inc stock is traded at $16.88, with a volume of 115.39K.
It is down -2.37% in the last 24 hours and down -1.72% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
See More
Previous Close:
$17.30
Open:
$17.27
24h Volume:
115.39K
Relative Volume:
0.63
Market Cap:
$1.14B
Revenue:
-
Net Income/Loss:
$-46.13M
P/E Ratio:
-20.78
EPS:
-0.8123
Net Cash Flow:
$-34.10M
1W Performance:
+0.03%
1M Performance:
-1.72%
6M Performance:
-19.09%
1Y Performance:
+46.28%
1-Day Range:
$16.75
$17.50
1-Week Range:
$16.75
$18.26
52-Week Range:
$9.70
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
16.88 | 1.14B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
553.29 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.36 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.18 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.13 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.55 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 23, 2025 - BioSpace
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Bank of America Corp DE Has $13.73 Million Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Tower Research Capital LLC TRC Has $29,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Transcript : Pulse Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 05 - marketscreener.com
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Earnings Call: Progress and Challenges - TipRanks
Barclays PLC Raises Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Reports Q1 2025 Financial Results - TipRanks
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wells Fargo & Company MN Purchases 2,416 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - BioSpace
Earnings Flash (PLSE) Pulse Biosciences Q1 Loss $0.25 Vs. $0.18 Loss Year Ago - marketscreener.com
Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com
PULSE BIOSCIENCES, INC. SEC 10-Q Report - TradingView
Pulse Biosciences Inc Reports Q1 2025 Financial Results: GAAP Net Loss of $16.8 Million, Cash Reserves at $119.3 Million - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Techno - GuruFocus
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
Pulse Biosciences (PLSE) Faces Criticism Over Technology's Past Performance | PLSE Stock News - GuruFocus
PLSE Faces Skepticism over Nano-Pulse Stimulation's Commercial V - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Technology | PLSE Stock News - GuruFocus
After the recent decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's holdings have lost 4.2% of their value - simplywall.st
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Stock Titan
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by Legal & General Group Plc - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Invesco Ltd. - Defense World
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - BioSpace
Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | PLSE Stock News - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business - Yahoo Finance
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - The Joplin Globe
Revolutionary Nanosecond PFA Heart Treatment Takes Center Stage at HRS 2025: J&J Partnership Revealed - Stock Titan
Trading (PLSE) With Integrated Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World
KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
0.04%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):